Clarivate Analytics plc, a global leader in providing trusted insights and analytics to accelerate the pace of innovation, has signed alliance agreements with three new technology partners. The partnerships will see Clarivate combine content from its CortellisTM suite of life science intelligence solutions with partners’ tools and technologies to help drug and medical device developers be better positioned for clinical and financial success.
The new partners include: Blueprint Systems, Copyright Clearance Center and Remarque Systems.
Blueprint Systems is a Gartner-recognised agile planning and compliance management software provider that accelerates and de-risks the digital transformation of large organisations. Its exclusive collaboration with Clarivate tackles one of the biggest challenges in life sciences - efficiently and successfully managing the complex regulatory compliance and GxP process.
Copyright Clearance Center (CCC) provides solutions that combine licensing, content, software and professional services to advance the way companies integrate, access and share information. Through its partnership with Clarivate, CCC has expanded the capabilities of its RightFind® Navigate discovery solution, which provides contextualised information retrieval of internal and external data to meet the specific needs of each user.
A leader in innovative clinical research methods, Remarque Systems optimises clinical trials through data using its cloud-based platform. Clarivate and Remarque are exploring ways to leverage Cortellis Clinical Trials intelligence in Remarque’s AI-driven quality oversight and trial optimisation software.
As a result of the partnerships, life sciences companies can expect to see better return on their investment in data and content by optimising their R&D budgets. The combined solutions will drive workflow efficiencies by making it easier to track information and manage data, which means teams can free up resources to focus on more strategic work rather than manually compiling and maintaining complex information sets. The extended solutions will also enable users to better access and interpret data in new ways, helping them move from research to insights and decision-making much faster.
The enhanced capabilities from the combination with partner solutions will be enabled by Cortellis Cloud™, an integrated, scalable technology platform that hosts Cortellis. Through Cortellis Cloud, millions of datapoints from thousands of sources are harmonised within a single unified platform, making it the industry’s richest resource for data-driven insights and advanced analytics.
Cortellis intelligence spans the entire R&D lifecycle and includes 2 million+ molecular interactions, 2.9 million+ pharmacology data points, 560,000+ drugs and biologics, 340,000+ clinical trials, 95,000+ deals, 200,000+ regulatory documents and 177,000+ company profiles, among other content.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.Click here to read the original press release.